🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study will be to evaluate the safety of a single dose o...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-10
Trial ID
NCT01450098
Elvitegravir is an HIV-1 integrase inhibitor which is marketed in a fixed d...
Status
Completed
Location
CRCN, Radboud University Medical Center
Start Date
2015-02
Trial ID
NCT02325934
Treatments Being Tested
The purpose of this study is to determine and compare the glycaemic index v...
Status
Completed
Location
Human Nutrition Unit, The University of Sydney
Start Date
2013-06
Trial ID
NCT01870570
This study was to investigate the pharmacokinetic (PK) and safety of M2951 ...
Status
Completed
Location
CRS Clinical Research Services Kiel GmbH
Start Date
2020-09-30
Trial ID
NCT04546789
Treatments Being Tested
The purpose of this study is to assess the BA of 30 or 60 milligram (mg) de...
Status
Completed
Location
Celerion
Start Date
2019-01-10
Trial ID
NCT03801148
In this pilot study it will be investigated if a whole grain product will i...
Status
Completed
Location
Aventure AB
Start Date
2021-05-06
Trial ID
NCT04888559
Treatments Being Tested
Our trial aims to assess the effect of nutraceutical supplements (omega-3 f...
Status
Terminated
Location
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Start Date
2018-05-01
Trial ID
NCT05393843
Treatments Being Tested
The objective of this study is to assess bioequivalence of lumacaftor from ...
Status
Completed
Location
BioPharma Services Inc.
Start Date
2023-11-17
Trial ID
NCT05968612
This is an open-label, crossover, randomized, single dose, three treatments...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05-31
Trial ID
NCT02498288
The aim of this study is to evaluate the bioequivalence and safety of Tamsu...
Status
Active Not Recruiting
Location
"Tonus-Les" LLC
Start Date
2025-06-16
Trial ID
NCT07091669
Treatments Being Tested